SARAJEVO (Bosnia and Herzegovina), December 22 (SeeNews) – The net profit of Bosnian drug maker Bosnalijek [SAJ:BSNLR] soared to 3.2 million marka ($2.0 million/1.6 million euro) in the first nine months of 2014 from 152,000 marka a year earlier, company data indicated.
Sales revenues rose 14.4% to 83.5 million marka through September, Bosnalijek said on its website.
The company’s earnings before interest and taxes (EBIT) jumped to 4.7 million marka in the first nine months of 2014 from 1.7 million marka a year ago.
(1 euro=1.95583 Bosnian marka)